Bullish Moving Averages
10
Bearish Moving Averages
6
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
4592.60Today’s High
4641.4052W low
3772.0052W High
5018.20Open Price
4625.00Prev. Close
4897.6000Volume
3027.00Value
13965669.90Fundamentals
Market Cap Cr
21106.60
Price to Earnings
38.30
Price to Book Value
5.90
Dividend Yield
0.90
PE to Growth
-3.30
Op Revenue TTM Cr
2193.17
Net Profit TTM Cr
551.33
Cash From Operating Activity Cr
256.84
Return on Equity %
15.33
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
52.7
Week
55.8
Month
61.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
4619.93
PIVOT
First Resistance
4659.87
Second Resistance
4699.53
Third Resistance
4739.47
First Support
4580.27
Second Support
4540.33
Third Support
4500.67
Relative Strength Index
48.85
Money Flow Index
13.59
MACD
-6.69
MACD Signal
22.18
Average True Range
118.06
Average Directional Index
21.31
Rate of Change (21)
-1.57
Rate of Change (125)
7.68
Commodity Channel Index
-60.1
Williams %R
-70.1
BETA
1 Month
0.39
3 Month
0.43
1 Year
0.33
3 Year
0.17
PRICE CHANGE ANALYSIS
↑ 1.96%
1 Week
Low
High
4509
4659.6
↓ -1.71%
1 Month
Low
High
4501
5018.15
↑ 6.61%
3 Months
Low
High
4075
5018.15
↑ 4.96%
6 Months
Low
High
3950
5018.15
↑ 21.87%
1 Year
Low
High
3772
5018.15
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 621.76 | 575.82 | 611.28 | 564.82 | 604.02 | 649.16 | 661.71 | 610.92 | 566.78 | 694.16 | 651.29 | |
| Operating Expenses Qtr | 357.20 | 387.42 | 392.60 | 420.65 | 390.77 | 418.30 | 405.78 | 401.05 | 384.21 | 480.73 | 446.89 | |
| Operating Profit Qtr | 189.43 | 152.55 | 182.61 | 110.71 | 181.87 | 203.45 | 231.69 | 191.85 | 165.45 | 195.17 | 189.37 | |
| EBIDT Qtr Cr | 264.56 | 196.35 | 218.68 | 144.17 | 193.66 | 230.86 | 444.85 | 73.54 | 182.57 | 213.43 | 204.40 | |
| Depreciation Qtr | 13.75 | 17.55 | 15.43 | 15.55 | 26.41 | 26.34 | 26.25 | 26.51 | 33.61 | 27.16 | 27.23 | |
| Net Profit Qtr | 178.86 | 129.98 | 148.96 | 93.53 | 129.65 | 150.66 | 311.07 | 32.55 | 125.79 | 143.91 | 142.95 | |
| Basic EPS Qtr | 22.33 | 27.12 | 32.56 | 20.44 | 28.34 | 32.93 | 67.99 | 7.11 | 27.50 | 31.46 | 31.25 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2373.68 | 2525.81 | 2673.64 | 2319.67 | 2335.67 | |
| Operating Expenses Annual Cr | 1557.87 | 1615.90 | 1775.26 | 1526.43 | 1579.09 | |
| Operating Profit Annual | 635.30 | 808.86 | 835.73 | 712.12 | 572.56 | |
| Operating Profit Margin Annual % | 26.76 | 32.02 | 31.26 | 30.70 | 24.51 | |
| Total Expenses Annual Cr | 1635.56 | 1734.80 | 1900.75 | 1650.95 | 1693.18 | |
| EBIDT Annual Cr | 815.81 | 909.91 | 898.38 | 793.24 | 756.58 | |
| EBIDT Annual margin % | 34.37 | 36.02 | 33.60 | 34.20 | 32.39 | |
| Depreciation | 62.28 | 105.51 | 115.00 | 109.41 | 103.24 | |
| PAT Before ExtraOrdinary Items Annual Cr | 551.33 | 623.93 | 612.56 | 497.61 | 509.13 | |
| Net Profit Annual | 551.33 | 623.93 | 612.56 | 497.61 | 509.13 | |
| Basic EPS Annual | 120.51 | 128.50 | 133.89 | 108.77 | 111.28 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3595.54 | 3207.30 | 2864.41 | 2393.04 | 3395.49 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 86.68 | 136.08 | 183.21 | 98.52 | 136.55 | |
| Total Current Liabilities Annual Cr | 546.56 | 657.35 | 852.89 | 774.34 | 873.36 | |
| Total Capital Plus Liabilities Annual Cr | 4228.78 | 4000.73 | 3900.51 | 3265.90 | 4405.40 | |
| Fixed Assets Annual | 713.11 | 757.18 | 870.28 | 897.06 | 973.62 | |
| Total Non Current Assets Annual | 1459.22 | 1475.64 | 1504.03 | 1341.19 | 1357.15 | |
| Total Current Assets Annual | 2769.56 | 2525.09 | 2396.48 | 1924.71 | 3048.25 | |
| Total Assets Annual | 4228.78 | 4000.73 | 3900.51 | 3265.90 | 4405.40 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 437.83 | 338.14 | 254.98 | 254.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 256.84 | 355.68 | 667.08 | 427.33 | 323.18 | |
| Cash from Investing Activity Annual | 53.70 | -36.05 | -575.02 | -468.84 | 1530.32 | |
| Cash from Financing Annual Activity | -235.14 | -345.79 | -180.51 | -1571.07 | -163.52 | |
| Net Cash Flow Annual | - | -26.16 | -88.45 | -1612.58 | 1689.98 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 785.91 | 701.05 | 626.10 | 523.07 | 742.18 | |
| ROE Annual % | 15.33 | 19.45 | 21.38 | 20.79 | 14.99 | |
| ROCE Annual % | 20.46 | 24.05 | 25.70 | 27.44 | 18.49 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 37.19 | 37.52 | 34.40 | 35.43 | 35.16 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| PFIZER EAST INDIA B V | 39.75 | 74798736 | 0 | 0 |
| WYETH LLC | 12.28 | 74798737 | 0 | 0 |
| WYETH HOLDINGS CORPORATION | 3.56 | 74798738 | 0 | 0 |
| WARNER-LAMBERT COMPANY LLC | 2.6 | 74798739 | 0 | 0 |
| PARKE, DAVIS & COMPANY LLC | 2.09 | 74798740 | 0 | 0 |
| JOHN WYETH & BROTHER LTD | 1.93 | 74798741 | 0 | 0 |
| PHARMACIA CORPORATION | 1.71 | 74798742 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND | 3.75 | 74798745 |
| UTI NIFTY MIDCAP 150 QUALITY 50 INDEX FUND | 1.02 | 74798746 |
| LIFE INSURANCE CORPORATION OF INDIA | 5.79 | 74798748 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ATUL LIMITED | 2.1 | 74798763 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 11, 2023 | 5 | SPECIAL | Aug 11, 2023 | Equity Share |
| Aug 11, 2023 | 35 | FINAL | Aug 11, 2023 | Equity Share |
| Sep 19, 2022 | 30 | SPECIAL | Sep 20, 2022 | Equity Share |
| Aug 18, 2022 | 35 | FINAL | Aug 19, 2022 | Equity Share |
| Aug 11, 2021 | 5 | SPECIAL | - | Equity Share |
| Aug 11, 2021 | 30 | FINAL | - | Equity Share |
| Aug 27, 2020 | 10 | FINAL | - | Equity Share |
| May 06, 2020 | 320 | SPECIAL | May 08, 2020 | Equity Share |
| Aug 01, 2019 | 22.5 | FINAL | - | Equity Share |
| Aug 29, 2018 | 20 | FINAL | - | Equity Share |
| Aug 22, 2017 | 5 | SPECIAL | - | Equity Share |
| Aug 22, 2017 | 15 | FINAL | - | Equity Share |
| Jun 27, 2016 | 15 | FINAL | - | Equity Share |
| Jul 03, 2015 | 12.5 | FINAL | - | Equity Share |
| Dec 05, 2013 | 360 | INTERIM | Dec 06, 2013 | Equity Share |
| Aug 28, 2013 | 32.5 | FINAL | - | Equity Share |
| Jul 24, 2012 | 12.5 | FINAL | - | Equity Share |
| Jul 08, 2011 | 4 | FINAL | - | Equity Share |
| Jan 20, 2011 | 12.5 | INTERIM | Jan 21, 2011 | Equity Share |
| Apr 15, 2010 | 12.5 | FINAL | - | Equity Share |
| Mar 31, 2009 | 12.5 | FINAL | - | Equity Share |
| Apr 03, 2008 | 27.5 | FINAL | - | Equity Share |
| Mar 09, 2007 | 12.5 | FINAL | - | Equity Share |
| Apr 10, 2006 | 10 | FINAL | - | Equity Share |
| Apr 13, 2005 | 10 | FINAL | - | Equity Share |
| Apr 16, 2004 | 7.5 | FINAL | - | Equity Share |
| Oct 13, 2003 | 7.5 | FINAL | - | Equity Share |
| Apr 15, 2002 | - | FINAL | - | Equity Share |
| Mar 23, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 17, 2024 | Audited Results & Final Dividend | - |
| Feb 09, 2024 | Quarterly Results | - |
| Oct 28, 2023 | Quarterly Results | - |
| Aug 11, 2023 | Quarterly Results | - |
| May 15, 2023 | Audited Results & Final Dividend | - |
| Feb 09, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 05, 2022 | Quarterly Results | - |
| May 20, 2022 | Audited Results & Dividend | - |
| Feb 03, 2022 | Quarterly Results | - |
| Nov 03, 2021 | Quarterly Results | - |
| Jul 28, 2021 | Quarterly Results | - |
| May 26, 2021 | Audited Results & Dividend | - |
| Feb 05, 2021 | Quarterly Results | - |
| Nov 02, 2020 | Quarterly Results | - |
| Jul 27, 2020 | Quarterly Results | - |
| Jun 15, 2020 | Audited Results & Final Dividend | - |
| Apr 27, 2020 | Interim Dividend | - |
| Feb 14, 2020 | Quarterly Results | - |
| Oct 26, 2019 | Quarterly Results | - |
| Aug 09, 2019 | Quarterly Results | - |
| May 28, 2019 | Audited Results & Final Dividend | - |
| Jan 24, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 02, 2018 | Quarterly Results | - |
| May 07, 2018 | Audited Results & Dividend | - |
| Jan 24, 2018 | Quarterly Results | - |
| Nov 10, 2017 | Quarterly Results | - |
| Jul 29, 2017 | Quarterly Results | - |
| May 06, 2017 | Special Dividend | - |
| Jan 30, 2017 | Quarterly Results | - |
| Nov 04, 2016 | Quarterly Results | - |
| Aug 05, 2016 | Quarterly Results | - |
| May 06, 2016 | Audited Results & Dividend | - |
| Feb 03, 2016 | Quarterly Results | - |
| Nov 09, 2015 | Quarterly Results | - |
| Jul 25, 2015 | Quarterly Results | - |
| May 05, 2015 | Audited Results & Dividend | - |
| Feb 14, 2015 | Quarterly Results | - |
| Nov 06, 2014 | Quarterly Results | - |
| Jul 24, 2014 | Quarterly Results | - |
| May 02, 2014 | Audited Results & Final Dividend | - |
| Jan 31, 2014 | Quarterly Results | - |
| Nov 23, 2013 | Interim Dividend & Amalgamation | inter alia, to transact the following; 1 To consider declaration of Interim Dividend. 2. To consider a Scheme of Amalgamation of the Wyeth Ltd with company. |
| Nov 11, 2013 | Quarterly Results | - |
| Jul 26, 2013 | Quarterly Results | - |
| May 14, 2013 | Audited Results & Dividend | - |
| May 03, 2013 | Audited Results & Dividend | - |
| Feb 07, 2013 | Quarterly Results | - |
| Nov 08, 2012 | Quarterly Results | - |
| Aug 13, 2012 | Quarterly Results | - |
| May 21, 2012 | Audited Results & Dividend | - |
| Jan 27, 2012 | Quarterly Results | - |
| Jan 05, 2012 | Incorporation of a WoS | The Board has approved the incorporation of a WoS in the State of Maharashtra, with a view to spin off its animal health business to such entity as a pre-step to subsequent sale to a WoS of Pfizer Inc |
| Oct 24, 2011 | Quarterly Results | - |
| Aug 01, 2011 | Quarterly Results | - |
| May 03, 2011 | Audited Results & Final Dividend | - |
| Jan 11, 2011 | Quarterly Results & Interim Dividend | For the 4th quarter ended November 30,2010. |
| Oct 06, 2010 | Quarterly Results | - |
| Jul 12, 2010 | Quarterly Results | - |
| Mar 26, 2010 | Quarterly Results | - |
| Mar 19, 2010 | Audited Results | To reconsider the Annual Financial Results of the Merged entity (i.e. Pfizer Ltd & Duchem Laboratories Ltd.) with a view to give effect to the Court Order dated February 26, 2010 of Bombay High Court. |
| Feb 25, 2010 | Audited Results & Dividend | The Board has recommended a dividend of Rs. 12.50 (125%) per Equity Share for the year ended November 30, 2009 which was intimated vide letter dated February 25, 2010. |
| Sep 26, 2009 | Quarterly Results & Amalgamation | To approve the Scheme of Amalgamation of Duchem Laboratories Ltd (WoS of Pfizer Ltd) and Pfizer Ltd., The Scheme is proposed to be effective December 01, 2008. |
| Jun 27, 2009 | Quarterly Results | - |
| Mar 28, 2009 | Quarterly Results | - |
| Jan 30, 2009 | Audited Results & Dividend | - |
| Sep 30, 2008 | Quarterly Results | - |
| Jun 30, 2008 | Quarterly Results | - |
| Mar 31, 2008 | Quarterly Results | - |
| Feb 25, 2008 | Audited Results & Dividend | - |
| Sep 24, 2007 | Quarterly Results | - |
| Jun 28, 2007 | Quarterly Results | - |
| Mar 22, 2007 | Quarterly Results | - |
| Jan 20, 2007 | Accounts & Dividend | - |
| Sep 30, 2006 | Quarterly Results | (Revised) |
| Jun 28, 2006 | Quarterly Results | - |
| Mar 28, 2006 | Quarterly Results | - |
| Feb 27, 2006 | Accounts & Dividend | - |
| Sep 26, 2005 | Quarterly Results | - |
| Jun 27, 2005 | Half Yearly Results | - |
| Mar 30, 2005 | Quarterly Results | - |
| Feb 24, 2005 | Dividend & Accounts | - |
| Jul 13, 2004 | Amalgamation | To consider a proposal for the amalgamation of Pharmacia Healthcare Ltd (PHL) into Pfizer Ltd pursuant to a Scheme of Amalgamation will be placed before the Board of Directors for its consideration. |
| Jun 30, 2004 | Half Yearly Results | - |
| Mar 30, 2004 | Quarterly Results | - |
| Feb 26, 2004 | Dividend & Accounts | (Revised) |
| Sep 26, 2003 | Quarterly Results | for 28.02.03 and 31.05.03 |
| Mar 31, 2003 | Quarterly Results | - |
| Feb 26, 2003 | Accounts & Dividend | - |
| Oct 03, 2002 | Quarterly Results | - |
| Jun 27, 2002 | Half Yearly Results & Amalgamation | Amalgamation of Parke-Davis (India) Ltd. with the co. |
| Mar 14, 2002 | Quarterly Results | - |
| Jan 29, 2002 | Accounts & Dividend | - |
| Sep 26, 2001 | Quarterly Results | - |
| Jun 30, 2001 | Half Yearly Results | - |
| Mar 31, 2001 | Quarterly Results | - |
| Feb 06, 2001 | Accounts & Dividend | Dividend announced on 06/02/2001 |
| Sep 22, 2000 | Quarterly Results | - |
| Jun 22, 2000 | Quarterly Results | - |
| Mar 11, 2000 | Quarterly Results | - |
| Jan 29, 2000 | Accounts and Dividend | - |
| Sep 28, 1999 | Quarterly Results | - |
| Jun 22, 1999 | Half Yearly Results | - |
| Mar 23, 1999 | Quarterly Results | - |
| Jan 27, 1999 | Accounts & Dividend | - |
| Sep 29, 1998 | Quarterly Results | - |
| Jun 27, 1998 | Half Yearly Results(Revised) | - |
| Nov 21, 1997 | Half Yearly Results | - |
| Jun 27, 1997 | Accounts & Final Dividend. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jun 12, 2000 | 1:1 | 2000-06-28 |
02 Jul 2024
Pfizer, Moderna Covid vaccine patents battle to continue after UK ruling
Moderna had argued Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the Covid-19 pandemic began in late 2019
28 Jun 2024
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificates and issue of Letter of Confirmation.
28 Jun 2024
PFIZER LTD. - 500680 - Closure of Trading Window
Intimation regarding Closure of Trading window for declaration of unaudited financial results for the quarter ended June 30, 2024.
26 Jun 2024
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for Loss of Share Certificates and issue of Letter of Confirmation.
22 Jun 2024
PFIZER LTD. - 500680 - Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of SEBI (LODR), 2015 we wish to inform you that Company has received an order issued by the Deputy Commission, State Tax, Dehradun.
18 Jun 2024
US' Kansas sues Pfizer for hiding Covid vaccine risks, making false claims
The lawsuit filed by Kansas, a US state, alleged that Pfizer promoted its vaccine's safety while hiding evidence linking it to pregnancy complications, such as miscarriages, and heart inflammations
07 Jun 2024
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of shares and issue of Letter of Confirmation.
30 May 2024
PFIZER LTD. - 500680 - Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Company has received an Order on May 29, 2024 issued by Joint Commissioner of State Tax, Raipur Division - 1, Chhattisgarh (First Appellate Authority).
30 May 2024
Pfizer, Yashoda Hospitals open CoE for adult vaccinationin Hyderabad
Pfizer India and Yashoda Hospitals launch adult vaccination CoE to combat vaccine-preventable diseases in India effectively
27 May 2024
PFIZER LTD. - 500680 - Auditor'S Report For The Financial Year Ended March 31, 2024.
We refer to our letter dated May 17, 2024, informing you about the Audited Financial Results for the financial year ended March 31, 2024, Statement of Assets and Liabilities as on March 31, 2024, Statement of Audited Cash Flows for the year ended March 31, 2024 and Declaration with respect to unmodified opinion. We wish to bring to your notice that by oversight the Auditor''s Report was not attached with the said filing. Please find attached Auditor''s Report dated May 17, 2024, by our Statutory Auditors, M/s. B.S.R. & Co. LLP. Please note that there are no changes in the Audited Financial Results for the year ended March 31, 2024, published on May 17, 2024. Request you to please take the above on record.
